Table 3.

PFS and OS of LGSC population by prognostic factors (multivariate analysis).

	N	Adj. HRa (PFS)	P †	Adj. HRa (OS)	P †
Age years	189	1.00 (0.99–1.01)	0.769	1.00 (0.99–1.02)	0.838
Race/ethnicity
White	172	Referent	–	Referent	–
Black	9	0.42 (0.19–0.92)	0.031	0.59 (0.21–1.66)	0.317
Other	8	0.65 (0.28–1.48)	0.304	1.32 (0.54–3.24)	0.538
Performance status
0	93	Referent	–	Referent	–
1–2	87	1.26 (0.90–1.78)	0.181	1.47 (1.00–2.17)	0.048
3	9	0.84(0.40–1.78)	0.648	1.16 (0.53–2.53)	0.719
FIGO stage
III	165	Referent	–	Referent	–
IV	24	1.30 (0.81–2.08)	0.282	1.04 (0.61–1.76)	0.890
Baseline CA-125U/mL	184	1.11 (0.97–1.27)	0.137	1.13 (0.98–1.30)	0.094
Ascites
No	69	Referent	–	Referent	–
Yes	118	1.21 (0.81–1.80)	0.344	1.18 (0.76–1.82)	0.465
Residual disease status
Microscopic	47	Referent	–	Referent	–
0.1–1.0 cm	97	3.13 (1.96–4.98)	<0.001	2.31 (1.37–3.90)	0.002
>1.0 cm	45	3.31 (1.87–5.85)	<0.001	2.45 (1.30–4.64)	0.006

Tests used

^†Wald test.

^aHazard ratios (HR) are unitless. HRs are followed by their 95% confidence intervals.